AI takes on kidney biopsies: could it match expert pathologists?

NCT ID NCT07330362

Recruiting now Diagnosis Sponsor: Zhujiang Hospital Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated May 06, 2026 · Updated 19 times

Summary

This study is testing an artificial intelligence (AI) system that reads kidney biopsy images to help diagnose chronic kidney disease. About 2,900 people with suspected chronic kidney disease will have their biopsy images reviewed by both the AI and expert pathologists. The goal is to see how well the AI's diagnosis matches the pathologists' gold standard, focusing on accuracy, sensitivity, and specificity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Nanfang Hospital
RECRUITING

Guangzhou, Guangdong, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Zhujiang Hospital of Southern Medical University
RECRUITING

Guangzhou, Guangdong, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHRONIC GLOMERULONEPHRITIS CHRONIC KIDNEY DISEASE